Besides, Kaplan–Meier survival analysis showed that higher PRRX2 expression patients' median survival time was shorter than patients with lower PRRX2 expression in CGGA and TCGA GBM datasets (Fig. 5i, j). Here, PRRX2 is linked to glioblastoma.